Medtronic Global Holdings S.C.A., founded in 1949 and headquartered in Luxembourg, operates as a leading global healthcare solutions company dedicated to alleviating pain, restoring health, and extending life for patients worldwide. The company specializes in medical devices and therapies across a variety of sectors, including cardiovascular, diabetes management, and neuromodulation.
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Medtronic began issuing bonds to finance its expansion and acquisitions, with notable issuances in 2011 when it raised $3.7 billion to fund its purchase of Covidien. Recent bond offerings have displayed competitive yields, remaining attractive compared to industry peers, with 10-year bonds currently trading at approximately 3.25%. The company has also been active in the sustainability bond market, issuing green bonds to support environmentally friendly projects within its operations.